The global cell culture market is estimated to be valued at USD 22.56 Bn in 2024 and is expected to exhibit a CAGR of 11.8% during the forecast period (2024-2031). The cell culture market has seen significant growth in the last few decades driven by advancements in biomedical research and therapeutics development. Cell culture involves growing living cells in a specially formulated growth media under controlled conditions and has various applications in biomanufacturing, drug discovery, toxicity testing, and tissue engineering. It allows the large scale production of cells and cell products and helps scientists study their behaviors outside the natural environment within an organism. Modern cell culture techniques help gain insights into cellular functioning at a molecular level and aid the development of new pharmaceutical drugs and medical devices.
Market Dynamics:
The cell culture market is driven by the growing demand for biopharmaceuticals developed using cell lines, rising prevalence of chronic and genetic diseases, and increasing R&D expenditure by pharmaceutical companies for drug discovery. However, high setup and maintenance costs of cell culture laboratories limit the growth of this market. On the other hand, technological advancements including three dimensional cell culture systems and the development of serum-free and chemically defined media offer lucrative opportunities for market expansion. Additionally, the growing demand for regenerative medicine and tissue engineering applications of cell culture present remunerative opportunities. Stringent regulatory approval process remains a challenge.
Key Features of the Study:
- This report provides an in-depth analysis of the global cell culture market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cell culture market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickson and Company, Evonik, Promocell GmbH, Hi-Media Laboratories, Sekisui XenoTech LLC, Lonza Group, Agilent Technologies Inc., Cytiva, 300MICRONS GmbH, PL BioScience GmbH, and denovoMATRIX GmbH.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cell culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture market.
Market Segmentation
- Product:
- Consumables
- Instruments
- Culture Systems
- Cryostorage Equipment
- Biosafety Equipment
- Incubators
- Centrifuges
- Others
- Application:
- Biopharmaceutical Production
- Tissue Culture & Engineering
- Toxicity Testing
- Drug Development
- Cell & Gene Therapy
- Others
- End User:
- Biopharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- CMO & CRO
- Others
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Merck KGaA
- Sartorius AG
- BioSpherix, Ltd.
- Cell Culture Company, LLC
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Becton, Dickson and Company
- Evonik
- Promocell GmbH
- Hi-Media Laboratories
- Sekisui XenoTech LLC
- Lonza Group
- Agilent Technologies Inc.
- Cytiva
- 300MICRONS GmbH
- PL BioScience GmbH
- denovoMATRIX GmbH